Multidisciplinary approach to management of hipofibrinogenaemia in pregnancy, a case report
Sažetak
Inherited fibrinogen disorders introduce risk for recurrent abortions, sub-chorionic haematoma, placental abruption and postpartum haemorrhage. This is a case report of a successful pregnancy outcome in a 37-year old woman with hypofibrinogenaemia. She was referred to a coagulation test in the first trimester because of history of preeclampsia and HELLP syndrome in previous pregnancy. Hypofibrinogenaemia was diagnosed with fibrinogen level of 0.7 g/L. During the pregnancy she was regularly monitored for fibrinogen levels and multiple cryoprecipitate concentrates were given. She delivered at 39th gestation week, with elective caesarean section under general anaesthesia. There was one episode of postpartum haemorrhage treated with 2 units of red blood cells, repeated infusions of cryoprecipitate to obtain the level of fibrinogen of 2 g/L. She was discharged on the 6th postpartum day in a good condition. In these disorders levels of fibrinogen should be higher than 1 g/L during pregnancy or 2 g/L in case of caesarean section for successful prenatal and peripartal management.
Reference
2 Jarmila A. Zdanowicz, Daniel Surbek . Patient blood management in obstetrics – Review. Transfusion and Apheresis Science. August 2019Volume 58, Issue 4, Pages 412–415/
3. De Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update. Semin Thromb Hemost 2013; https://www.ncbi.nlm.nih.gov/pubmed/23852822
4. Casini A, de Moerloose P. Management of congenital quantitative fibrinogen disorders: a Delphi consensus. Haemophilia 2016; https://www.ncbi.nlm.nih.gov/pubmed/27640400
5. Pritchard JA. Chronic hypofibrinogenemia and frequent placental abruption. Report of a case. Obstet Gynecol 1961/ https://www.ncbi.nlm.nih.gov/pubmed/13738090
6. L. Hahn, P. A. Lundberg, A. C. Teger‐Nilsson, CONGENITAL HYPOFIBRINOGENAEMIA AND RECURRENT ABORTION. CASE REPORT, BJOG, October 1978 //https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/j.1471-0528.1978.tb15605.x
7. Teraoka Y, Miyoshi H, Oshima K, Urabe S, Tanaka N, Kudo Y. Prenatal and peripartum management of patients with hypofibrinogenemia resulted in two successful deliveries. Case Rep Obstet Gynecol 2017; https://www.ncbi.nlm.nih.gov/pubmed/28286684
8. Mensah PK, Oppenheimer C, Watson C, Pavord S. Congenital afibrinogenaemia in pregnancy. Haemophilia 2011; https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2141.2000.01993.x
9.Lebreton A, Casini A, Alhayek R, Kouteich KL, Neerman-Arbez M, de Moerloose P. Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis. Haemophilia 2015; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815641/
10. Michael W. Mosesson. Dysfibrinogenemia and Thrombosis. Semin Thromb Hemost 1999; 25(3): 311-319. DOI: 10.1055/s-2007-994933; https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-2007-994933
11. Yan J, Deng D, Cheng P, Liao L, Luo M, Lin F. Management of dysfibrinogenemia in pregnancy: A case report. J Clin Lab Anal. 2018 Mar;32(3). doi: 10.1002/jcla.22319. Epub 2017 Sep 26.
12. Munoz J, Schering J, Lambing A, Neal S, Goyert G, Green PM, Hanbali A, Raman S, Kuriakose P. The dilemma of inherited dysfibrinogenemia during pregnancy. Blood Coagul Fibrinolysis. 2012 Dec;23(8):775-7. doi: 10.1097/MBC.0b013e328358e96d.
13. Kobayashi T, Kanayama N, Tokunaga N, Asahina T, Terao T. Prenatal and peripartum management of congenital afibrinogenaemia. Br J Haematol 2000; https://www.ncbi.nlm.nih.gov/pubmed/10848826
14. Shapiro SE, Diagnosis and management of dysfibrinogenemia. Clinical Advances in Heematology&Oncology.2018.16(9):602-605). https://www.hematologyandoncology.net/archives/september-2018/diagnosis-and-management-of-dysfibrinogenemia/
15. Kohler HP. Interaction between FXIII and fibrinogen. Blood. 2013; 121 (11): 1931–1932). https://ashpublications.org/blood/article/121/11/1931/31051/Interaction-between-FXIII-and-fibrinogen
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).